Jian Irish
See Remarks at Metagenomi Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 1 board, counting each seat separately. Longest: Metagenomi Therapeutics Inc., 2 years.
Metagenomi Therapeutics Inc.
Director · See Remarks
Chief executive roles
Metagenomi Therapeutics Inc.
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 5, 2026 | Metagenomi Therapeutics Inc. | Open-market sale | −3,737 | $1.30 | $4,858 |
| Apr 1, 2026 | Metagenomi Therapeutics Inc. | Grant or award | +46,000 | — | — |
| Mar 5, 2026 | Metagenomi Therapeutics Inc. | Open-market sale | −1,607 | $1.60 | $2,571 |
| Dec 5, 2025 | Metagenomi Therapeutics Inc. | Open-market sale | −1,602 | $1.77 | $2,836 |
| Dec 5, 2025 | Metagenomi Therapeutics Inc. | Gift | −228,462 | — | — |
| Dec 1, 2025 | Metagenomi Therapeutics Inc. | Grant or award | +37,500 | $1.60 | $60,000 |
| Dec 1, 2025 | Metagenomi Therapeutics Inc. | Grant or award | +211,000 | $1.60 | $337,600 |
| Sep 5, 2025 | Metagenomi Therapeutics Inc. | Open-market sale | −1,602 | $1.81 | $2,900 |
| Jun 6, 2025 | Metagenomi Therapeutics Inc. | Open-market sale | −6,390 | $1.75 | $11,183 |
| Apr 1, 2025 | Metagenomi Therapeutics Inc. | Grant or award | +23,000 | — | — |
| Apr 1, 2024 | Metagenomi Therapeutics Inc. | Grant or award | +70,471 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.